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Abstract
The key elements of psychiatric assessment of ability to work are an objective
evaluation of function, accurate differential diagnostics, and finding out the
clinical and non-clinical reasons behind disability. Here, we present a case with
prolonged disability due to disseminated borreliosis that first mimicked burnout, then
unipolar depression, and finally, bipolar mood disorder. The important clues of
organic neuropsychiatric syndrome were severe cognitive deficits which were
disproportionate regarding previous psychiatric diagnoses and a significant and
enduring decline of function in the clinical picture. An atypical clinical picture
with treatment-refractory psychiatric symptoms should prompt further consultations.
Although very rare, the possibility of disseminated borreliosis is worth keeping
mind, because the prognosis of late neuropsychiatric, untreated symptoms and prolonged
disability is poor.
Introduction
Referral to psychiatric assessment of ability to work with objective evaluation of
function and re-evaluation of diagnostics often leads to new treatment and
rehabilitation strategies with positive outcomes among patients with a complicated
disability. The return to work rate of psychiatric patients, however, is decreased
after half a year of absence from work, and remarkably decreased after year of
absence, independent of the reason for absence (1). The delay in vocational
rehabilitation is common among psychiatric patients (2). This case report presents the
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difficulties in differential diagnosis and adequate treatment of disseminated
borreliosis due to overlapping, multiple symptoms and challenges in laboratory
diagnostics. The diagnosis of disseminated borreliosis is very rare, with a prevalence
of less than 0.01% (3), compared to more common burnout 2.5% (4), unipolar depression
6.5% (5) and bipolar mood disorder 0.24% to 0.72% (6, 7).
Contemporary working life sets high demands for cognitive functions and ability to
cope with stress. Work can be rewarding in many ways, but symptoms of stress and
burnout can appear if work demands outweigh the means of recovery. Typical symptoms
are fatigue, sleep disturbances, difficulties with memory and concentration and
depression. If prolonged, these symptoms can decrease the ability to work and lead to
absence from work. The psychological triad of occupational burnout has become a
focus of interest in media and business, as well as a popular explanation for problems
at work. It is less stigmatizing than psychiatric diagnosis and thus often more
welcomed by the patients. When correct, the diagnosis of burnout is useful in leading
to reassessment of work load and employee coping skills with subsequent
interventions (8). But when not correct, it may confuse the identification of medical
and psychiatric syndromes and delay their treatment. Unclear somatic complaints are
very common in the working age population. Underlying psychological stress or even mild
psychiatric syndromes can be found, instead of severe somatic illness. This case again
makes an exception, with a distinctive warning sign of objectively deteriorated
function and non-response to psychological or psychiatric approaches.
Lyme borreliosis is an infection caused by spirochetes Borrelia burgdorferi,
transmitted by Ixodes ticks. It is the most common tick-borne infectious disease in
countries with a moderate climate (9). By the infectious character of the disease, it
can be classified as local or disseminated borreliosis. Based on anatomical damage
of the disseminated form, it can be divided into neuroborreliosis or borreliosis
arthritis. The disseminated form can also be divided as early and late dissemination
(10, 11). In Finland, it has been estimated that there are approximately 4000 borrelia
infections yearly and the majority of these are local, early-stage infections
restricted to skin. The number of patients with disseminated borreliosis has been
estimated to be at least 400 yearly (3). In disseminated borreliosis, a central
nervous system infection can be diagnosed (3, 9). Headache, facial paresis, memory
disorders, tiredness and attention problems are common symptoms (12). Psychiatric
symptoms such as depression, mania and panic disorder have also been recognized as
manifestations of disseminated borreliosis (13, 14), but their existence has been
questioned (15). The challenge in diagnosing central nervous system involvement in
disseminated borreliosis is that the serum levels of borrelia antibodies can be normal
and only cerebrospinal fluid (CSF) antibodies reveal the underlying disease (16).
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Case report
We report a case of a 46-year-old man who was referred to the Helsinki University
Central Hospital’s (HUCH) Psychiatric Outpatient unit for assessment of ability to
work because of treatment-refractory depression and prolonged disability.
The patient did not have a family history for neurologic or psychiatric disorders.
Despite a successful career as an information technology designer, his performance at
work had gradually deteriorated during the last decade. He had noticed tickbites in
years 2001 and 2002 while sailing in the Finnish archipelago. Over the following two
years he had visited occupational health care due to insomnia, a lowered ability to
cope with stress, and subjective complaints regarding memory and concentration. These
symptoms were attributed to occupational burnout. He also suffered from increasing
musculoskeletal and chest pains. Due to facial paresis, the blood serology for
borrelia antibodies was controlled, but it was negative. Comprehensive clinical
evaluation was done and he was diagnosed with fibromyalgia and Prinzmetal angina in
2005.
Two years after the second tickbite, the patient had his first long sickleave of
several months due to pain symptoms, exhaustion and sleep disturbance. When he
returned to work his mood was elevated and irritable, his need for sleep was reduced,
his self-esteem was inflated. He was abnormally talkative, restless, distractible and
overactive. The hypomanic episode in 2004 remained undiagnosed and lasted almost a
year. Although the patient recognized some harmfulness of his distractibility and
agitation, he still welcomed the overactive state wishing to get back his
characteristic premorbid energetic and vigorous state. After the hypomanic episode,
the patient had his first depressive episode and he also suffered from mixed anxiety
symptoms. His mood was low, but his exhaustion was even more remarkable. He did not
respond to antidepressants and psychosocial support. A neuropsychological examination
discovered problems in attention and concentration leading to disturbances in
short-term memory. Brain magnetic resonance image (MRI) was normal.
In 2009 the patient’s working rate had slowed down considerably, and he could no longer
concentrate in meetings or make calculations. He forgot names and discussions. His
work was modified, but he could not even manage his reduced tasks, or part-time
working. Laboratory tests and brain MRI were repeated and the findings were normal. A
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polysomnography indicated a moderate to severe sleep apnea with some clues of
central apnea and Cheyne-Stokes respiration. Obesity, unhealthy habits and addictions
were excluded as aetiological factors. Continuous positive airway pressure (CPAP)
treatment showed no response, but in the next polysomnography a month later the sleep
apnea was only mild. Subsequently the initial abnormalities were attributed to
nocturnal panic attacks.
Because of poor treatment response and problems with memory and concentration he was
sent to neuropsychological assessment in 2011. A broad neuropsychological examination
showed fatigue, a mild disturbance in attention control and a moderate disturbance of
working memory. The results did not meet the criteria for early dementia. The patient
was referred to a psychiatric open care unit for intensified treatment of moderate
depression and anxiety. There was again no treatment response to pharmacological and
psychosocial interventions. However, the patient was motivated to try to go back to work.
A gradual return to work with part-time sickleave was designed after 1.5 years of
absence from work, but the patient’s cognitive performance was insufficient for the
work and his depressive symptoms increased during the 4 months of working.
From spring 2012 he was on sickleave again. He was depressed and afraid of dying due
to frequent chest pain attacks. Thus he avoided all stress until the next mood shift
and his second hypomania, when his inactivity turned into overactivity. On a sudden
impulsive decision, he travelled alone by bike around Europe and across the Alps,
which was considered as exceptional and risk-taking behaviour by his family. Next
autumn, in depressive phase again, the patient was referred by his psychiatrist to
HUCH in 2012 for re-evaluation of function, ability to work and differential
diagnosis. The then present diagnosis of moderate depression and panic disorder were not
enough to explain the severe difficulties of function in daily life and the failure to
return to work. The psychiatric assessment of ability to work consisted of
lifehistory and daily life interview, structured diagnostic interviews and symptom
screens, laboratory screen, family and workplace interviews, collecting all previous
medical records, and in this case, clinical psychological examination and neurological
consultation.
The patient was depressive and exhausted. He was co-operative and logical, but his
psychomotor function was remarkably slow. The psychomotor retardation could have been
typical of severe depressive episode, but unlike that he did not express typical
depressive ideas and cognitive distortions. Despite history of burnout, he expressed
no professional cynicism, nor did he blame his work. He had been devoted to his work,
but before the initial pain and cognitive symptoms, he had always been good at coping
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with work stress and he had loved challenges at work. The patient himself did not
consider his exhaustion to be caused by work. The history of burnout symptoms was not
typical, because the exhaustion was not preceded by an experience of adverse
occupational stress nor an altered workload. The patient recognized his mood symptoms,
but he could not find the psychological logic for them, except for being devastated
by losing his function and ability to work.
The observations of the patient’s lowered function in daily life and at work were in
line with patient’s subjective report and the clinical observations during assessment.
His performance had slowed down remarkably compared to premorbid level. He was
unable to concentrate on longer discussions or to keep his papers in order.
He had difficulties finishing a sentence or remembering what he was going to say.
He described difficulties in writing SMS text messages with his cell phone or tapping
billcodes on a computer keyboard. He still suffered from joint stiffness and pain,
besides he still had a mild left-sided residual facial paresis. Laboratory screens
were normal. History of addictions was ruled out.
In psychological examination, the main findings were problems with concentration,
especially when the level of demand increased, and his impulse control was reduced.
The problem-solving skills were considerably lower than expected from a previously high
functioning individual. The ability to retrieve newly learned verbal information had
further deteriorated since his previous neuropsychological examination. The
retrieval of stored information, like words, was also deteriorated. The slowing of mental
processing was obvious. The cognitive deficits, in comparison to his primary level,
were disproportionate in relation to his psychiatric diagnosis and state.
In disseminated borreliosis, the patients typically have deficits in attention and
executive functions, in verbal and visual memory and response or processing speed
(17-20), like in this case. Although the borrelia serology in the blood had been
repeatedly negative, a CSF sample was taken. In the CSF, increased
borrelia IgG antibodies (5.9 wME) were found, and the IgM was normal. There was also
an increase in CSF total protein (518 mg/l). After this, the blood serology was
carried out with a different method, revealing elevated levels of borrelia IgG
antibodies (15VE/ml).The patient was referred to HUCH Unit of Infectious Diseases and
he was then diagnosed by two separate infectious disease specialists as having a late
stage of disseminated borreliosis. Based on a Finnish multicentre study with a
relatively large number of patients concerning the antimicrobial treatment of
disseminated borreliosis (11), our patient was due to be treated with 3 weeks of
intravenous ceftriaxone. However, after 10 days this treatment was discontinued
because of elevated liver enzymes. Thereafter his treatment was followed with
doxycycline 100 mg twice a day for 3 months.
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The late onset antimicrobial therapy had no remarkable effect on cognitive deficits,
but during prolonged doxycycline treatment, his joint symptoms improved. By then, the
mood was stabilized, but some depressive symptoms still persisted, such as tiredness,
low initiative, psychomotor retardation and poor concentration, which could be
attributed to the organic neuropsychiatric syndrome of disseminated borreliosis. The
organic bipolar mood disorder had not responded to mood stabilizers that were the
first symptom-based treatment trial before antibiotics were introduced. Small dose
quetiapine alleviated insomnia and was better tolerated than lamotrigine and the
previous antidepressive medications. The patient was granted disability pension after
receiving a diagnosis of organic bipolar disorder and cognitive deficits due to
disseminated borreliosis that explained his fluctuating and variable,
treatment-refractory symptoms and lowered function.
Discussion
This case report has described an unfortunate patient with late stage disseminated
borreliosis. Besides musculoskeletal pain, the exhaustion and cognitive symptoms first
imitated work stress and burnout symptoms. Cognitive deficits were worsened with the
onset of bipolar symptoms. Disseminated borreliosis has previously been associated
with depression, but a recent case history describes a manic psychosis caused by
borrelia encephalitis (21). After series of unsuccessful treatments for unipolar
depression, the patient was diagnosed with an organic bipolar mood disorder. However,
the present marked cognitive dysfunction was associated more with disseminated
borreliosis than mood disorder. The prognosis of organic neuropsychiatric symptoms due
to late disseminated borreliosis is worse than the prognosis of bipolar mood disorder,
which is often treatable by adequate psychiatric care.
Our patient had several opportunities for tick bites, because his hobby was to sail in the
Finnish archipelago during summer, which is known as a high-risk area for borreliosis
(3). His symptoms started after the first tick bites about 10 years ago. His initial
symptoms were musculoskeletal pains, later neurocognitive abnormalities were found.
Regarding the patient’s severe clinical picture, there might have been more tick bites
than those two that he clearly identified after having removed the bothering ticks
from the sensitive skin area. The diagnosis of disseminated borreliosis was based on
identified tick bites, clinical picture examined by two separate infectious disease
specialists supported with spinal fluid findings and by elevated blood borrelia IgG
antibodies. The microbiological definite diagnosis of disseminated borreliosis,
however, can be difficult as shown by a previous Finnish study (22).
                                                             27
Kostamo et al.
Psychiatria Fennica 2015;46:21-31
Burnout, bipolar or borreliosis?
A diagnostic dilemma behind
prolonged disability
Our patient was due to be treated with 3 weeks of intravenous ceftriaxone. However,
after 10 days the treatment was discontinued because of elevated liver enzymes. During
this period his joint symptoms had not improved. Matrix metalloproteinases (MMPs) and
especially MMP-8 mediated inflammatory response have been shown to play a significant
role in disseminated borreliosis (23-27), and particularly among those patients who
have persistent joint symptoms after treatment with beta-lactam antibiotics like
ceftriaxone (25-27). While our patient, after a beta-lactam antibiotic, still suffered
from joint stiffness and pain, his treatment was followed with prolonged doxycycline,
100 mg twice a day, as used in reactive arthritis (27-29), because long-lasting joint
symptoms in disseminated borreliosis have been considered as reactive arthritis (25,
30-34). Doxycycline treatment was also chosen because there are several European
studies showing that doxycycline is an efficient drug in disseminated borreliosis
(35-38). The important role of MMP-8 in infection-induced systemic inflammatory
response, also regarding central nervous system involvement, suggests its role as a
therapeutic target (39). Tetracycline antibiotics, such as doxycycline, have been
shown to inhibit MMP-8 by several mechanisms (31-34). As the prognosis of late stage
disseminated borreliosis is poor, an early diagnosis is vital. In endemic areas the
differential diagnostics of disseminated borreliosis should be considered in atypical
and treatment-refractory psychiatric illness (12, 40).
Occupational burnout is considered to be a negative consequence of chronic work stress
and defined as a three-dimensional psychological syndrome of emotional exhaustion,
professional cynicism and lack of professional efficacy (41, 42). Burnout predicts
health deterioration, future sick leaves and disability pensions due to somatic and
psychiatric disorders (42). Severe burnout is often accompanied by somatic and
psychiatric comorbidity, such as musculoskeletal disorders 46.7%, cardiovascular
diseases 27.6%, depressive disorders 45.3% and anxiety disorders 21.0% (41), which
were all diagnosed with our patient. Unlike most burnout cases, our patient himself
never really agreed with the clinical judgement of burnout, but he was compliant.
In this case, the exhaustion was primarily due to organic neuropsychiatric symptoms,
and secondarily, due to the patient’s efforts to keep up with previous
productivity despite lowered cognitive capacity. Insomnia, and later, the depressive
episodes also explained some part of the exhaustion. Despite a feeling of diminished
professional efficacy and accomplishment, there is no clinically remarkable
deterioration of function in burnout. The objective findings of cognitive functions
are contradictory: a population sample with burnout symptoms may perform even better
than average people (43), but clinical burnout cases seem to underperform compared to
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their healthy controls (44). Burnout seems to be associated with slight and reversible
cognitive impairment (45). The subjective experience of cognitive problems is more
severe than the objective cognitive deficits among burnout patients (44). In
depression, the experience of diminished performance and failure is broader and more
painful, it is not limited to work and besides, there is a more obvious objective
decrease of function and ability to work than in burnout.
This case shows how important it is to integrate all the symptoms and signs in the
clinical picture across medical specialties. The presentation of burnout syndrome is
always a warning sign of unhealthy occupational stress and of an elevated risk for
morbidity and future disability. Besides occupational health care professionals,
employers and managers should also react if the symptoms of burnout are present.
Emphasis should be in early intervention and co-operation with employee, manager and
occupational health care. The prognosis is usually good, but without an evident
aetiological connection to workload and working conditions, the hypothesis of burnout
should be discarded. Even with a justified diagnosis of burnout, the possibility of
comorbid somatic and psychiatric illness should be considered. When exhaustion at work
is preceded by mood disorder or inflammatory disease, it is rather a symptom of
illness or a consequence of lowered performance due to illness. Re-evaluation of
diagnosis should be considered if the work ability and work-related symptoms do not
improve with support, correct treatment and work modifications.
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